Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Gastric Cancer

Free Subscription Articles published in J Surg Oncol Retrieve available abstracts of 59 articles: HTML format Text format

Single Articles

March 2019
1. WANG F, Hu YL, Feng Y, Guo YB, et al
   High-level expression of PRSS3 correlates with metastasis and poor prognosis in patients with gastric cancer.
   J Surg Oncol. 2019 Mar 25. doi: 10.1002/jso.25448.
   PubMed     Text format     Abstract available
   
   
   February 2019
2. ZHAO B, Leichman LP, Horgan S, Bouvet M, et al
   Evaluation of treatment and outcomes for Hispanic patients with gastric cancer at Commission on Cancer-accredited centers in the United States.
   J Surg Oncol. 2019 Feb 11. doi: 10.1002/jso.25408.
   PubMed     Text format     Abstract available
   
   
   
3. AGNES A, Biondi A, Cananzi FM, Rausei S, et al
   Ratio-based staging systems are better than the 7th and 8th editions of the TNM in stratifying the prognosis of gastric cancer patients: A multicenter retrospective study.
   J Surg Oncol. 2019 Feb 11. doi: 10.1002/jso.25411.
   PubMed     Text format     Abstract available
   
   
   January 2019
4. RHOME RM, Ru M, Moshier E, Mazumdar M, et al
   Stage-matched survival differences by ethnicity among gastric cancer patients of Asian ancestry treated in the United States.
   J Surg Oncol. 2019 Jan 29. doi: 10.1002/jso.25389.
   PubMed     Text format     Abstract available
   
   
   
5. DRAKE J, Schreiber KC, Lopez R, Fasaye GA, et al
   Establishing a center of excellence for hereditary diffuse gastric cancer syndrome.
   J Surg Oncol. 2019 Jan 7. doi: 10.1002/jso.25363.
   PubMed     Text format    
   
   
   December 2018
6. JIANG Z, Sun L, Yang W, Li J, et al
   Excessive expectations for carcinoembryonic antigen targeted fluorescent-guided surgery for sentinel lymph node detection in colorectal, pancreatic, and gastric cancer.
   J Surg Oncol. 2018 Dec 3. doi: 10.1002/jso.25318.
   PubMed     Text format    
   
   
   November 2018
7. ZAIDI MY, Rappaport JM, Ethun CG, Gillespie T, et al
   Identifying the barriers to gastric cancer care at safety-net hospitals: A novel comparison of a safety-net hospital to a neighboring quaternary referral academic center in the same healthcare system.
   J Surg Oncol. 2018 Nov 27. doi: 10.1002/jso.25299.
   PubMed     Text format     Abstract available
   
   
   
8. SHINKAI M, Imano M, Chiba Y, Iwama M, et al
   Phase II trial of neoadjuvant chemotherapy with intraperitoneal paclitaxel, S-1, and intravenous cisplatin and paclitaxel for stage IIIA or IIIB gastric cancer.
   J Surg Oncol. 2018 Nov 15. doi: 10.1002/jso.25295.
   PubMed     Text format     Abstract available
   
   
   October 2018
9. HE M, Jiang Z, Wang C, Hao Z, et al
   Diagnostic value of near-infrared or fluorescent indocyanine green guided sentinel lymph node mapping in gastric cancer: A systematic review and meta-analysis.
   J Surg Oncol. 2018 Oct 31. doi: 10.1002/jso.25285.
   PubMed     Text format     Abstract available
   
   
   
10. GUO X, Peng Z, Lv X, Cui J, et al
    Randomized controlled trial comparing short-term outcomes of laparoscopic and open spleen-preserving splenic hilar lymphadenectomy for advanced proximal gastric cancer: An interim report.
    J Surg Oncol. 2018 Oct 31. doi: 10.1002/jso.25262.
    PubMed     Text format     Abstract available
    
    
    
11. MARTIN AN, Silverstein A, Ssebuufu R, Lule J, et al
    Impact of delayed care on surgical management of patients with gastric cancer in a low-resource setting.
    J Surg Oncol. 2018 Oct 31. doi: 10.1002/jso.25286.
    PubMed     Text format     Abstract available
    
    
    
12. ARROYO-MARTINEZ Q, Han WH, Eom BW, Yoon HM, et al
    The distribution pattern of metastatic lymph nodes after non-curative endoscopic resection in early gastric cancer.
    J Surg Oncol. 2018 Oct 27. doi: 10.1002/jso.25279.
    PubMed     Text format     Abstract available
    
    
    
13. LI P, Huang CM, Zheng CH, Russo A, et al
    Comparison of gastric cancer survival after R0 resection in the US and China.
    J Surg Oncol. 2018 Oct 17. doi: 10.1002/jso.25220.
    PubMed     Text format     Abstract available
    
    
    September 2018
14. VUIJK FA, Hilling DE, Mieog JSD, Vahrmeijer AL, et al
    Fluorescent-guided surgery for sentinel lymph node detection in gastric cancer and carcinoembryonic antigen targeted fluorescent-guided surgery in colorectal and pancreatic cancer.
    J Surg Oncol. 2018 Sep 14. doi: 10.1002/jso.25139.
    PubMed     Text format     Abstract available
    
    
    
15. SUZUKI M, Yokobori T, Gombodorj N, Yashiro M, et al
    High stromal transforming growth factor beta-induced expression is a novel marker of progression and poor prognosis in gastric cancer.
    J Surg Oncol. 2018 Sep 9. doi: 10.1002/jso.25217.
    PubMed     Text format     Abstract available
    
    
    
16. GIULIANO K, Ejaz A, Reames BN, Choi W, et al
    Comparing the long-term outcomes among patients with stomach and small intestine gastrointestinal stromal tumors: An analysis of the National Cancer Database.
    J Surg Oncol. 2018;118:486-492.
    PubMed     Text format     Abstract available
    
    
    
17. LI Z, Li S, Bu Z, Zhang L, et al
    The effect of preoperative treatments on lymph node counts after total gastrectomy in esophagogastric adenocarcinoma.
    J Surg Oncol. 2018;118:657-663.
    PubMed     Text format     Abstract available
    
    
    July 2018
18. KUKAR M, Gabriel E, Ben-David K, Hochwald SN, et al
    Laparoscopic proximal gastrectomy for gastric neoplasms.
    J Surg Oncol. 2018;118:95-100.
    PubMed     Text format     Abstract available
    
    
    
19. COHEN NA, Strong VE, Janjigian YY
    Checkpoint blockade in esophagogastric cancer.
    J Surg Oncol. 2018;118:77-85.
    PubMed     Text format     Abstract available
    
    
    June 2018
20. IKOMA N, Hofstetter WL, Estrella JS, Das P, et al
    The ypT category does not impact overall survival in node negative gastric cancer.
    J Surg Oncol. 2018 Jun 27. doi: 10.1002/jso.25081.
    PubMed     Text format     Abstract available
    
    
    
21. YU JJ, Li JD, Yang T
    Association between neutrophil-lymphocyte ratio and prognosis after potentially curative resection for gastric cancer.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25070.
    PubMed     Text format    
    
    
    
22. THIELS CA, Ikoma N, Fournier K, Das P, et al
    Repeat staging laparoscopy for gastric cancer after preoperative therapy.
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25094.
    PubMed     Text format     Abstract available
    
    
    
23. SZOR DJ, Dias AR, Pereira MA, Ramos MFKP, et al
    Reply to: "Association between neutrophil-lymphocyte ratio and prognosis after potentially curative resection for gastric cancer".
    J Surg Oncol. 2018 Jun 7. doi: 10.1002/jso.25069.
    PubMed     Text format    
    
    
    
24. LANE WO, Nussbaum DP, Sun Z, Blazer DG, et al
    Preoperative radiation therapy in the surgical management of gastric and junctional adenocarcinoma: Should lymph node retrieval guidelines be altered?
    J Surg Oncol. 2018;117:1708-1715.
    PubMed     Text format     Abstract available
    
    
    May 2018
25. KIM HS, Chon HJ, Kim H, Shin SJ, et al
    MET in gastric cancer with liver metastasis: The relationship between MET amplification and Met overexpression in primary stomach tumors and liver metastasis.
    J Surg Oncol. 2018 May 22. doi: 10.1002/jso.25097.
    PubMed     Text format     Abstract available
    
    
    
26. WEN J, Bedford M, Begum R, Mitchell H, et al
    The value of inflammation based prognostic scores in patients undergoing surgical resection for oesophageal and gastric carcinoma.
    J Surg Oncol. 2018 May 14. doi: 10.1002/jso.25057.
    PubMed     Text format     Abstract available
    
    
    March 2018
27. PEREIRA MA, Ramos MFKP, Faraj SF, Dias AR, et al
    Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
    J Surg Oncol. 2018 Mar 13. doi: 10.1002/jso.25022.
    PubMed     Text format     Abstract available
    
    
    
28. MARTINS MR, Santos RLD, Jatahy KDN, Matta MCD, et al
    Could OX40 agonist antibody promote activation of the anti-tumor immune response in gastric cancer?
    J Surg Oncol. 2018 Mar 12. doi: 10.1002/jso.25001.
    PubMed     Text format     Abstract available
    
    
    
29. SZOR DJ, Roncon Dias A, Pereira MA, Ramos MFKP, et al
    Neutrophil-lymphocyte ratio is associated with prognosis in patients who underwent potentially curative resection for gastric cancer.
    J Surg Oncol. 2018 Mar 6. doi: 10.1002/jso.25036.
    PubMed     Text format     Abstract available
    
    
    
30. MIZRAK KAYA D, Nogueras-Gonzalez GM, Harada K, Amlashi FG, et al
    Risk of peritoneal metastases in patients who had negative peritoneal staging and received therapy for localized gastric adenocarcinoma.
    J Surg Oncol. 2018;117:678-684.
    PubMed     Text format     Abstract available
    
    
    
31. GABRIEL E, Attwood K, Narayanan S, Brady M, et al
    Does neoadjuvant/perioperative chemotherapy improve overall survival for T2N0 gastric adenocarcinoma?
    J Surg Oncol. 2018;117:659-670.
    PubMed     Text format     Abstract available
    
    
    January 2018
32. NISHIZUKA SS, Tamura G, Nakatochi M, Fukushima N, et al
    Helicobacter pylori infection is associated with favorable outcome in advanced gastric cancer patients treated with S-1 adjuvant chemotherapy.
    J Surg Oncol. 2018 Jan 22. doi: 10.1002/jso.24977.
    PubMed     Text format     Abstract available
    
    
    December 2017
33. MURATA S, Yamamoto H, Shimizu T, Naitoh H, et al
    5-fluorouracil combined with cisplatin and mitomycin C as an optimized regimen for hyperthermic intraperitoneal chemotherapy in gastric cancer.
    J Surg Oncol. 2017 Dec 19. doi: 10.1002/jso.24906.
    PubMed     Text format     Abstract available
    
    
    
34. IKOMA N, Cloyd J, Badgwell BD, Agnes A, et al
    Clinical features and survival of gastric cancer patients with DNA mismatch repair deficiency.
    J Surg Oncol. 2017 Dec 11. doi: 10.1002/jso.24926.
    PubMed     Text format     Abstract available
    
    
    
35. LI K, Cannon JGD, Jiang SY, Sambare TD, et al
    Diagnostic staging laparoscopy in gastric cancer treatment: A cost-effectiveness analysis.
    J Surg Oncol. 2017 Dec 4. doi: 10.1002/jso.24942.
    PubMed     Text format     Abstract available
    
    
    
36. LEE JH, Tanaka E, Woo Y, Ali G, et al
    Advanced real-time multi-display educational system (ARMES): An innovative real-time audiovisual mentoring tool for complex robotic surgery.
    J Surg Oncol. 2017;116:894-897.
    PubMed     Text format     Abstract available
    
    
    November 2017
37. LIU X, Li G, Long Z, Yin J, et al
    Phase II trial of preoperative chemoradiation plus perioperative SOX chemotherapy in patients with locally advanced gastric cancer.
    J Surg Oncol. 2017 Nov 30. doi: 10.1002/jso.24917.
    PubMed     Text format     Abstract available
    
    
    
38. CHOI WJ, Moon JH, Min JS, Song YK, et al
    Real-time detection system for tumor localization during minimally invasive surgery for gastric and colon cancer removal: In vivo feasibility study in a swine model.
    J Surg Oncol. 2017 Nov 28. doi: 10.1002/jso.24922.
    PubMed     Text format     Abstract available
    
    
    August 2017
39. DUAN W, Liu K, Fu X, Shen X, et al
    Semi-end-to-end esophagojejunostomy after laparoscopy-assisted total gastrectomy better reduces stricture and leakage than the conventional end-to-side procedure: A retrospective study.
    J Surg Oncol. 2017;116:177-183.
    PubMed     Text format     Abstract available
    
    
    July 2017
40. MURATA S, Yamamoto H, Naitoh H, Yamaguchi T, et al
    Feasibility and safety of hyperthermic intraperitoneal chemotherapy using 5-fluorouracil combined with cisplatin and mitomycin C in patients undergoing gastrectomy for advanced gastric cancer.
    J Surg Oncol. 2017 Jul 25. doi: 10.1002/jso.24771.
    PubMed     Text format     Abstract available
    
    
    
41. CHEN XD, Mao CC, Zhang WT, Lin J, et al
    A quantified risk-scoring system and rating model for postsurgical gastroparesis syndrome in gastric cancer patients.
    J Surg Oncol. 2017 Jul 25. doi: 10.1002/jso.24691.
    PubMed     Text format     Abstract available
    
    
    June 2017
42. SON SY, Kong SH, Ahn HS, Park YS, et al
    The value of N staging with the positive lymph node ratio, and splenectomy, for remnant gastric cancer: A multicenter retrospective study.
    J Surg Oncol. 2017 Jun 26. doi: 10.1002/jso.24737.
    PubMed     Text format     Abstract available
    
    
    
43. SAUNDERS JH, Bowman CR, Reece-Smith AM, Pang V, et al
    The role of adjuvant platinum-based chemotherapy in esophagogastric cancer patients who received neoadjuvant chemotherapy prior to definitive surgery.
    J Surg Oncol. 2017;115:821-829.
    PubMed     Text format     Abstract available
    
    
    May 2017
44. BUSWEILER LAD, Dikken JL, Henneman D, van Berge Henegouwen MI, et al
    The influence of a composite hospital volume on outcomes for gastric cancer surgery: A Dutch population-based study.
    J Surg Oncol. 2017 May 15. doi: 10.1002/jso.24562.
    PubMed     Text format     Abstract available
    
    
    
45. LORENZON L, Cippitelli C, Avantifiori R, Uccini S, et al
    Down-regulated miRs specifically correlate with non-cardial gastric cancers and Lauren's classification system.
    J Surg Oncol. 2017 May 5. doi: 10.1002/jso.24648.
    PubMed     Text format     Abstract available
    
    
    March 2017
46. GIULIANO K, Nagarajan N, Canner J, Najafian A, et al
    Gastric and small intestine gastrointestinal stromal tumors: Do outcomes differ?
    J Surg Oncol. 2017;115:351-357.
    PubMed     Text format     Abstract available
    
    
    February 2017
47. RUSSO A, Li P, Strong VE
    Differences in the multimodal treatment of gastric cancer: East versus west.
    J Surg Oncol. 2017 Feb 9. doi: 10.1002/jso.24517.
    PubMed     Text format     Abstract available
    
    
    December 2016
48. RONA KA, Schwameis K, Zehetner J, Samakar K, et al
    Gastric cancer in the young: An advanced disease with poor prognostic features.
    J Surg Oncol. 2016 Dec 23. doi: 10.1002/jso.24533.
    PubMed     Text format     Abstract available
    
    
    November 2016
49. FEINGOLD PL, Kwong ML, Davis JL, Rudloff U, et al
    Adjuvant intraperitoneal chemotherapy for the treatment of gastric cancer at risk for peritoneal carcinomatosis: A systematic review.
    J Surg Oncol. 2016 Nov 23. doi: 10.1002/jso.24476.
    PubMed     Text format     Abstract available
    
    
    
50. POLOM K, Marrelli D, Roviello G, Pascale V, et al
    Molecular key to understand the gastric cancer biology in elderly patients-The role of microsatellite instability.
    J Surg Oncol. 2016 Nov 18. doi: 10.1002/jso.24513.
    PubMed     Text format     Abstract available
    
    
    October 2016
51. IMAMURA T, Komatsu S, Ichikawa D, Kawaguchi T, et al
    Early signet ring cell carcinoma of the stomach is related to favorable prognosis and low incidence of lymph node metastasis.
    J Surg Oncol. 2016;114:607-612.
    PubMed     Text format     Abstract available
    
    
    
52. EL-HAGE A, Ruel C, Afif W, Wissanji H, et al
    Metastatic pattern of invasive lobular carcinoma of the breast-Emphasis on gastric metastases.
    J Surg Oncol. 2016;114:543-547.
    PubMed     Text format     Abstract available
    
    
    
53. POSTLEWAIT LM, Baptiste GG, Ethun CG, Le N, et al
    A 15-year experience with gastric neuroendocrine tumors: Does type make a difference?
    J Surg Oncol. 2016;114:576-580.
    PubMed     Text format     Abstract available
    
    
    September 2016
54. GERTLER R, Richter J, Stecher L, Nitsche U, et al
    What to do after R1-resection of adenocarcinomas of the esophagogastric junction?
    J Surg Oncol. 2016;114:428-33.
    PubMed     Text format     Abstract available
    
    
    
55. RUSSELL MC
    Comparison of neoadjuvant versus a surgery first approach for gastric and esophagogastric cancer.
    J Surg Oncol. 2016;114:296-303.
    PubMed     Text format     Abstract available
    
    
    August 2016
56. BAPTISTE GG, Postlewait LM, Ethun CG, Le N, et al
    Symptomatic presentation as a predictor of recurrence in gastroenteropancreatic neuroendocrine tumors: A single institution experience over 15 years.
    J Surg Oncol. 2016;114:163-9.
    PubMed     Text format     Abstract available
    
    
    June 2016
57. HERRERA-ALMARIO G, Patane M, Sarkaria I, Strong VE, et al
    Initial report of near-infrared fluorescence imaging as an intraoperative adjunct for lymph node harvesting during robot-assisted laparoscopic gastrectomy.
    J Surg Oncol. 2016;113:768-70.
    PubMed     Text format     Abstract available
    
    
    May 2016
58. SERRANO OK, Love C, Goldman I, Huang K, et al
    The value of FDG-PET in the staging of gastric adenocarcinoma: A single institution retrospective review.
    J Surg Oncol. 2016;113:640-6.
    PubMed     Text format     Abstract available
    
    
    April 2016
59. FUENTES E, Ahmad R, Hong TS, Clark JW, et al
    The impact of neoadjuvant therapy for gastroesophageal adenocarcinoma on postoperative morbidity and mortality.
    J Surg Oncol. 2016;113:560-4.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Gastric Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: